Comparative Effects of Teriparatide and Risedronate in Glucocorticoid-Induced Osteoporosis in Men: 18-Month Results of the EuroGIOPs Trial

Data on treatment of glucocorticoid-induced osteoporosis (GIO) in men are scarce. We performed a randomized, open-label trial in men who have taken glucocorticoids (GC) for ≥3 months, and had an areal bone mineral density (aBMD) T-score ≤ –1.5 standard deviations. Subjects received 20 μg/d teriparat...

Descripción completa

Detalles Bibliográficos
Autores principales: Glüer, Claus-C, Marin, Fernando, Ringe, Johann D, Hawkins, Federico, Möricke, Rüdiger, Papaioannu, Nikolaos, Farahmand, Parvis, Minisola, Salvatore, Martínez, Guillermo, Nolla, Joan M, Niedhart, Christopher, Guañabens, Nuria, Nuti, Ranuccio, Martín-Mola, Emilio, Thomasius, Friederike, Kapetanos, Georgios, Peña, Jaime, Graeff, Christian, Petto, Helmut, Sanz, Beatriz, Reisinger, Andreas, Zysset, Philippe K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708101/
https://www.ncbi.nlm.nih.gov/pubmed/23322362
http://dx.doi.org/10.1002/jbmr.1870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708101/
https://www.ncbi.nlm.nih.gov/pubmed/23322362
http://dx.doi.org/10.1002/jbmr.1870

Ejemplares similares